annb0t
Top 20
Medicare is the largest individual insurance payer of health costs in the country. So it's no wonder that drugmakers want its seal of approval for reimbursement.
That's especially true of the weight-loss drug market leaders Novo Nordisk (NVO) and Eli Lilly (LLY). Both companies have lobbied for support for a bill â the Treat and Reduce Obesity Act (TROA) â which has been reintroduced annually in Congress for over a decade, with little attention until recently.
The two companies are a...
>>> Read more: How Lilly is joining Novo in the crusade to circumvent Medicare's block on weight loss drugs
That's especially true of the weight-loss drug market leaders Novo Nordisk (NVO) and Eli Lilly (LLY). Both companies have lobbied for support for a bill â the Treat and Reduce Obesity Act (TROA) â which has been reintroduced annually in Congress for over a decade, with little attention until recently.
The two companies are a...
>>> Read more: How Lilly is joining Novo in the crusade to circumvent Medicare's block on weight loss drugs
